Treatment Overview
Targeted drug regimens and monoclonal antibody therapies customized based on genetic tumor profiling.
Procedure Details
Outpatient or inpatient infusion therapy with supportive care suite.
Starting Price: $1,400.00 • Success Rate: 85.0%